Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-08 09:17 am Sale |
2023-06-08 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Shin Nippon Biomedical Laboratories Ltd. | 1,000 100.000% |
-2,793,113 (-99.96%) |
Filing History |
| 2023-04-17 4:09 pm Unchanged |
2023-04-16 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Shin Nippon Biomedical Laboratories Ltd. | 2,794,113 8.400% |
0 (Unchanged) |
Filing History |
| 2022-08-12 06:44 am Purchase |
2022-06-16 | 13D | Wave Life Sciences Ltd. WVE |
Shin Nippon Biomedical Laboratories Ltd. | 9,666,408 10.600% |
3,771,930 (+63.99%) |
Filing History |
| 2021-03-31 08:52 am Purchase |
2021-02-26 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Shin Nippon Biomedical Laboratories Ltd. | 2,794,113 8.900% |
2,794,113 (New Position) |
Filing History |